Pyrotinib inhibits the tumorigenicity of HER2-positive non-small cell lung cancer by inducing ARIH1/ubiquitin/lysosome-dependent degradation of HER2. - Li, Xiyue; Wang, Jiehong; Li, Shu; Fang, Jing; Hao, Yue; Xu, Chunwei; Shu, You; Shu, Hong; Chen, Jiaojiao; Lu, Naiyan; Zhu, Xue; Wang, Ke; et al. (Cellular Oncology (2211-3428), 2025)